Difference between revisions of "BirthDefectsReporting FHIR IG Proposal"
Craig newman (talk | contribs) |
Craig newman (talk | contribs) |
||
Line 33: | Line 33: | ||
==Committee Approval Date:== | ==Committee Approval Date:== | ||
WG approval: May 16 2019 | WG approval: May 16 2019 | ||
+ | |||
FMG approval: May 22 2019 | FMG approval: May 22 2019 | ||
+ | |||
Clinical SD approval: June 3 2019 | Clinical SD approval: June 3 2019 | ||
Line 75: | Line 77: | ||
==Short Description== | ==Short Description== | ||
+ | The purpose of the Birth Defects Reporting FHIR IG is to provide guidance on reporting birth defects, either at the time of birth or afterwards, from a provider to a jurisdictional birth defects registry. The IG covers reporting requirements from both the ambulatory and hospital contexts. | ||
<!-- 1-2 sentences describing the purpose/scope of the IG for inclusion in the registry- this is the sentence that will be used here: http://www.fhir.org/guides/registry. This must describe the IG from the perspective of an implementer scanning a registry, it should not talk about the project and should NOT be copied from the PSS. --> | <!-- 1-2 sentences describing the purpose/scope of the IG for inclusion in the registry- this is the sentence that will be used here: http://www.fhir.org/guides/registry. This must describe the IG from the perspective of an implementer scanning a registry, it should not talk about the project and should NOT be copied from the PSS. --> | ||
Line 80: | Line 83: | ||
==Long Description== | ==Long Description== | ||
+ | The scope of this project is to produce and ballot a Standard for Trial Use (STU) Fast Healthcare Interoperability Resources (FHIR) implementation guide (IG) for use in reporting of birth defects in the U.S. to jurisdictional birth defect registries. Automation of the reporting process adds efficiencies that dramatically improves the efficacy of collecting data related to birth defects and patient outcomes. | ||
+ | |||
+ | The clinical content being exchanges will be derived from a birth defects domain analysis model (which itself is an extension of a vital records domain analysis model). Content areas include patient demographics, related persons (mother, father), labor and delivery events and patient conditions (birth defects). Reporting is covered not only at the time of birth, but also through later stages of childhood. | ||
<!-- 1-2 paragraphs describing the purpose/scope of the IG in more detail for inclusion in the version history - this is content that will be used in your IG's equivalent of this: http://www.hl7.org/fhir/us/core/history.cfml. Again, this must describe the IG from the perspective of an implementer scanning a registry, it should not talk about the project and should NOT be copied from the PSS. --> | <!-- 1-2 paragraphs describing the purpose/scope of the IG in more detail for inclusion in the version history - this is content that will be used in your IG's equivalent of this: http://www.hl7.org/fhir/us/core/history.cfml. Again, this must describe the IG from the perspective of an implementer scanning a registry, it should not talk about the project and should NOT be copied from the PSS. --> | ||
Line 85: | Line 91: | ||
==Involved parties== | ==Involved parties== | ||
− | + | The project is being sponsored by the state of Michigan but will include input from a variety of other jurisdictions as well as Health IT developers. | |
<!-- 1 paragraph describing who is sponsoring or involved in creating the IG **for inclusion in the version history**. Don't copy from the PSS - think about the specific language you want to appear in the registry. --> | <!-- 1 paragraph describing who is sponsoring or involved in creating the IG **for inclusion in the version history**. Don't copy from the PSS - think about the specific language you want to appear in the registry. --> | ||
==Expected implementations== | ==Expected implementations== | ||
− | + | The state of Michigan is expected to implement this IG in conjunction with healthcare organizations in the state. | |
<!--Provide named implementations if possible - ideally provide multiple independent implementations. --> | <!--Provide named implementations if possible - ideally provide multiple independent implementations. --> | ||
==Content sources== | ==Content sources== | ||
− | + | The Birth Defects domain analysis model will be the primary source of clinical content. The development of this DAM will consult the existing Vital Records DAM and reuse components where possible. Where requirements overlap, the US Core profiles will be used to directly or as the basis for developing unique birth defect reporting profiles. | |
<!-- List all of the specifications (beyond those in the "standard" (FHIR_Design_Requirements_Sources) list of source specifications) that you’re planning to consult | <!-- List all of the specifications (beyond those in the "standard" (FHIR_Design_Requirements_Sources) list of source specifications) that you’re planning to consult | ||
Line 100: | Line 106: | ||
==Example Scenarios== | ==Example Scenarios== | ||
− | + | Example scenarios include: | |
+ | 1) reporting of a newborn birth defect at the time of birth from a hospital context | ||
+ | 2) reporting birth defect identified later in life (during childhood) from an ambulatory context | ||
<!-- Provide a listing of the types of scenarios to be represented in the examples produced for this IG. They should demonstrate the full scope of the IG and allow exercising of the IG's capabilities (all profiles, different types of applications, etc.) --> | <!-- Provide a listing of the types of scenarios to be represented in the examples produced for this IG. They should demonstrate the full scope of the IG and allow exercising of the IG's capabilities (all profiles, different types of applications, etc.) --> | ||
==IG Relationships== | ==IG Relationships== | ||
− | + | This IG may overlap in patient-centric content with the vital records death reporting IG. Where possible, the two IGs will be harmonized. The IG will also use R4 US Core profiles where possible. | |
<!-- Are there any IGs this resource depends on or that depend on this IG? --> | <!-- Are there any IGs this resource depends on or that depend on this IG? --> | ||
==Timelines== | ==Timelines== | ||
− | + | Work on the IG will begin in early 2020 | |
+ | The anticipated ballot target date is September 2020 (meeting the standard FHIR IG deadlines for that ballot cycle) | ||
+ | Ballot reconciliation will happen in the fall of 2020 | ||
+ | A publication date is expected in late 2020 or early 2021 | ||
<!-- Indicate the target date for having the IGcomplete from a committee perspective and ready for vetting and voting --> | <!-- Indicate the target date for having the IGcomplete from a committee perspective and ready for vetting and voting --> | ||
Revision as of 17:20, 18 June 2019
Contents
- 1 Birth Defect Reporting FHIR IG
- 1.1 Owning work group name
- 1.2 Committee Approval Date:
- 1.3 Publishing Lead
- 1.4 Contributing or Reviewing Work Groups
- 1.5 FHIR Development Project Insight ID
- 1.6 Scope of coverage
- 1.7 Content location
- 1.8 Proposed IG realm and code
- 1.9 Maintenance Plan
- 1.10 Short Description
- 1.11 Long Description
- 1.12 Involved parties
- 1.13 Expected implementations
- 1.14 Content sources
- 1.15 Example Scenarios
- 1.16 IG Relationships
- 1.17 Timelines
- 1.18 When IG Proposal Is Complete
- 1.19 FMG Notes
Birth Defect Reporting FHIR IG
Owning work group name
Public Health
Committee Approval Date:
WG approval: May 16 2019
FMG approval: May 22 2019
Clinical SD approval: June 3 2019
Publishing Lead
Craig Newman - craig.newman_at_altarum.org
Contributing or Reviewing Work Groups
None
FHIR Development Project Insight ID
Project ID 1532
Scope of coverage
This proposal covers the reporting of birth defects for human patients up to the age of 12 years in the United States. Reporting is from a provider in either a hospital or ambulatory location to a jurisdictional birth defect registry. Reporting may happen at the time of birth or some time aftwards. Clinical content for reporting includes demographics and vital records content but also specific content related to the birth defect(s) for the patient.
Content location
TBD - is there a suggested github repository pathway?
Proposed IG realm and code
US
Maintenance Plan
Altarum works with the state of Michigan to develop and support their birth defect registry. This association is expected to continue after the publication of the IG.
Short Description
The purpose of the Birth Defects Reporting FHIR IG is to provide guidance on reporting birth defects, either at the time of birth or afterwards, from a provider to a jurisdictional birth defects registry. The IG covers reporting requirements from both the ambulatory and hospital contexts.
Long Description
The scope of this project is to produce and ballot a Standard for Trial Use (STU) Fast Healthcare Interoperability Resources (FHIR) implementation guide (IG) for use in reporting of birth defects in the U.S. to jurisdictional birth defect registries. Automation of the reporting process adds efficiencies that dramatically improves the efficacy of collecting data related to birth defects and patient outcomes.
The clinical content being exchanges will be derived from a birth defects domain analysis model (which itself is an extension of a vital records domain analysis model). Content areas include patient demographics, related persons (mother, father), labor and delivery events and patient conditions (birth defects). Reporting is covered not only at the time of birth, but also through later stages of childhood.
Involved parties
The project is being sponsored by the state of Michigan but will include input from a variety of other jurisdictions as well as Health IT developers.
Expected implementations
The state of Michigan is expected to implement this IG in conjunction with healthcare organizations in the state.
Content sources
The Birth Defects domain analysis model will be the primary source of clinical content. The development of this DAM will consult the existing Vital Records DAM and reuse components where possible. Where requirements overlap, the US Core profiles will be used to directly or as the basis for developing unique birth defect reporting profiles.
Example Scenarios
Example scenarios include: 1) reporting of a newborn birth defect at the time of birth from a hospital context 2) reporting birth defect identified later in life (during childhood) from an ambulatory context
IG Relationships
This IG may overlap in patient-centric content with the vital records death reporting IG. Where possible, the two IGs will be harmonized. The IG will also use R4 US Core profiles where possible.
Timelines
Work on the IG will begin in early 2020 The anticipated ballot target date is September 2020 (meeting the standard FHIR IG deadlines for that ballot cycle) Ballot reconciliation will happen in the fall of 2020 A publication date is expected in late 2020 or early 2021
When IG Proposal Is Complete
When you have completed your proposal, please send an email to FMGcontact@HL7.org